CUMBERLAND, R.I.--(BUSINESS WIRE)--Neurotech Pharmaceuticals, Inc. (the “Company”) today provided an update on its ongoing transition to a commercial‑stage company following the first anniversary of ...

Please provide your email address to receive an email when new articles are posted on . “The entire Neurotech family mourns this loss,” the company said in a statement. “On behalf of the board of ...

A number of pivotal announcements this year – including Neuralink’s first brain implant trial, and major funding rounds from companies such as Motif Neurotech with its miniaturized neurostimulator for ...

Forbes contributors publish independent expert analyses and insights. I’m an analyst covering neurotech's impact on business and society. Cognito Therapeutics announced a $105 million Series C round ...

Company reports continued clinical adoption, expanding reimbursement coverage, and established commercial manufacturing capacity Neurotech Pharmaceuticals, Inc. (the “Company”) today provided an ...